Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT).
Kossodo S, Pickarski M, Lin SA, Gleason A, Gaspar R, Buono C, Ho G, Blusztajn A, Cuneo G, Zhang J, Jensen J, Hargreaves R, Coleman P, Hartman G, Rajopadhye M, Duong LT, Sur C, Yared W, Peterson J, Bednar B.
Kossodo S, et al. Among authors: zhang j.
Mol Imaging Biol. 2010 Oct;12(5):488-99. doi: 10.1007/s11307-009-0279-z. Epub 2009 Dec 4.
Mol Imaging Biol. 2010.
PMID: 19960268